New injection aims to stop bladder leaks in spinal cord injury patients

NCT ID NCT06596291

Recruiting now Disease control Sponsor: EG 427 Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a single treatment of EG110A injections into the bladder muscle for adults with spinal cord injury who still have bladder leaks despite standard care. The goal is to see if the treatment is safe and can reduce incontinence. Sixteen participants will be followed for one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROGENIC DETRUSOR OVERACTIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROGENIC DETRUSOR OVERACTIVITY SPINAL CORD INJURIES

Contacts and locations

Locations

Rancho Los Amigos National Rehabilitation Center
RECRUITING

Downey, California, 90242, United States
Sidney Kimmel Medical College
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
UTHealth Houston / TIRR Memorial Hermann
RECRUITING

Houston, Texas, 77030, United States
University of Michigan Rogel Cancer Center
WITHDRAWN

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.